| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Bone Diseases, Metabolic | D001851 | 9 associated lipids |
| Adrenal Hyperplasia, Congenital | D000312 | 2 associated lipids |
| Obesity | D009765 | 29 associated lipids |
| Hypertension, Pulmonary | D006976 | 32 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Myocardial Infarction | D009203 | 21 associated lipids |
| Femur Head Necrosis | D005271 | 5 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Thyroid Neoplasms | D013964 | 33 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:27647720 | ||||
| pmid:27639566 | ||||
| Shirakawa J and Kulkarni RN | Novel factors modulating human β-cell proliferation. | 2016 | Diabetes Obes Metab | pmid:27615134 |
| Menzel J et al. | Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. | 2016 | J. Endocrinol. Invest. | pmid:27614458 |
| pmid:27608613 | ||||
| pmid:27608363 | ||||
| Xing R et al. | Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. | 2016 | Int. J. Mol. Med. | pmid:27599586 |
| pmid:27599364 | ||||
| pmid:27582133 | ||||
| Sun J et al. | Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. | 2016 | Int. Immunopharmacol. | pmid:27576059 |
| pmid:27571745 | ||||
| pmid:27563728 | ||||
| pmid:27552373 | ||||
| pmid:27541035 | ||||
| Yongdi L et al. | [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. | 2016 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:27526445 |
| pmid:27515196 | ||||
| Qian H et al. | FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. | 2016 | Mol Med Rep | pmid:27510616 |
| pmid:27505721 | ||||
| pmid:27503623 | ||||
| pmid:27501819 | ||||
| pmid:27493142 | ||||
| pmid:27491024 | ||||
| Jung YJ et al. | Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. | 2017 | Mol Oral Microbiol | pmid:27484636 |
| pmid:27475026 | ||||
| pmid:27469295 | ||||
| Røysland R et al. | Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. | 2016 | PLoS ONE | pmid:27463973 |
| pmid:27463412 | ||||
| Yu M et al. | Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. | 2016 Apr-Jun | J Cancer Res Ther | pmid:27461682 |
| Piemontese M et al. | Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27460899 |
| pmid:27460567 | ||||
| Zhao JJ et al. | MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. | 2016 | PLoS ONE | pmid:27459539 |
| pmid:27441597 | ||||
| pmid:27430581 | ||||
| pmid:27421098 | ||||
| Ugay L et al. | Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. | 2016 | Chin. Med. J. | pmid:27411457 |
| Pellegrini GG et al. | Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. | 2016 | Nutrients | pmid:27409635 |
| pmid:27409364 | ||||
| pmid:27394662 | ||||
| pmid:27391172 | ||||
| Nagy EE et al. | High circulating osteoprotegerin levels are associated with non-zero blood groups. | 2016 | BMC Cardiovasc Disord | pmid:27387019 |
| Zhang YY et al. | Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. | 2016 | Chin J Dent Res | pmid:27379348 |
| pmid:27377060 | ||||
| Dawson S and Lawrie A | From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. | 2017 | Pharmacol. Ther. | pmid:27373854 |
| Zhou QL et al. | Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. | 2016 | Mol Med Rep | pmid:27357904 |
| pmid:27342005 | ||||
| pmid:27341651 | ||||
| pmid:27339288 | ||||
| Songia P et al. | Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. | 2016 | J. Mol. Cell. Cardiol. | pmid:27338002 |
| Li Y et al. | OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. | 2016 | Medicine (Baltimore) | pmid:27336899 |
| Dolan EB et al. | Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo. | 2016 | J R Soc Interface | pmid:27335224 |